Margaret A Horn's Net Worth

$10.4 Million

Estimate Recalculated Nov 11, 2024 01:40PM EST

Who is Margaret A Horn

Margaret A Horn has an estimated net worth of $10.4 Million. This is based on reported shares across multiple companies, which include GENENCOR INTERNATIONAL INC, KOSAN BIOSCIENCES INC, Revolution Medicines, Inc., and SANGAMO THERAPEUTICS, INC.

SEC CIK

Margaret A Horn's CIK is 0001294192

Past Insider Trading and Trends

2023 was Margaret A Horn's most active year for acquiring shares with 11 total transactions. Margaret A Horn's most active month to acquire stocks was the month of February. 2023 was Margaret A Horn's most active year for disposing of shares, totalling 22 transactions. Margaret A Horn's most active month to dispose stocks was the month of February. 2005 saw Margaret A Horn paying a total of $1,081,500.00 for 150,000 shares, this is the most they've acquired in one year. In 2021 Margaret A Horn cashed out on 71,434 shares for a total of $1,967,200.19, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

GENENCOR INTERNATIONAL INC

Sr. VP, General Counsel, Sect.
Updated Apr 22, 2005
Form 4
-100.00%
-272.28K
$19.25
-$43.95K
Apr 22, 2005
Disposition
Apr 20 - Apr 21
Form 4
60.00K
Dec 13, 2004
272.28K
Grant
Dec 09
Form 4
45.00K
Jun 17, 2004
212.28K
Grant
Jun 15
Form 3
Jun 17, 2004
2.28K
Showing 4 results

KOSAN BIOSCIENCES INC

SVP, General Counsel
Updated Jan 04, 2007
Form 4
45.00K
Jan 04, 2007
45.00K
Grant
Jan 02
Form 4
20.00K
$4.46
$89.20K
Jan 05, 2006
20.00K
Grant
Jan 03
Form 4
150.00K
$7.21
$1.08M
Dec 06, 2005
150.00K
Grant
Dec 02
Form 3
Dec 06, 2005
Showing 4 results

Revolution Medicines, Inc.

Chief Operating Officer
Updated Oct 15, 2024
Form 4
-17.88%
-50.00K
$27.22
-$2.31M
Oct 15, 2024
229.70K
Sale
Oct 11
Form 4
-3.17%
-4.33K
$44.19
-$191.37K
Sep 18, 2024
132.32K
Sale
Sep 16
Form 4
-3.13%
-4.42K
$37.39
-$165.06K
Jun 20, 2024
136.65K
Sale
Jun 17
Form 4
-2.05%
-2.91K
$31.58
-$92.03K
Mar 20, 2024
139.55K
Sale
Mar 18
Form 4
-11.23%
-23.67K
$19.06
-$708.84K
Mar 13, 2024
187.10K
Sale
Mar 11 - Mar 12
Form 4
181.83%
184.50K
Mar 05, 2024
285.97K
Grant
Mar 01
Form 4
-4.50%
-7.99K
$15.23
-$190.26K
Dec 19, 2023
169.77K
Sale
Dec 15 - Dec 18
Form 4
-2.74%
-5.00K
$14.55
-$104.55K
Dec 08, 2023
177.76K
Sale
Dec 06
Form 4
$0.54
$4.05K
Oct 25, 2023
110.40K
Options
Oct 25
Form 4
-12.48%
-25.00K
$19.02
-$746.56K
Oct 18, 2023
175.26K
Sale
Oct 16
Form 4
-3.62%
-7.51K
$17.95
-$218.67K
Sep 19, 2023
200.26K
Sale
Sep 15 - Sep 18
Form 4
-4.59%
-10.00K
$19.07
-$299.56K
Sep 01, 2023
207.78K
Sale
Aug 31
Form 4
-2.24%
-5.00K
$17.31
-$132.18K
Aug 17, 2023
217.78K
Sale
Aug 15
Form 4
-2.07%
-2.10K
$24.89
-$52.32K
Jun 22, 2023
99.47K
Sale
Jun 20
Form 4
-1.21%
-1.23K
$21.78
-$26.79K
Mar 21, 2023
100.06K
Sale
Mar 17
Form 4
293.68%
180.00K
Mar 03, 2023
241.29K
Grant
Mar 01
Form 4
-1.95%
-1.22K
$22.94
-$27.99K
Dec 21, 2022
61.29K
Sale
Dec 19
Form 4
-100.00%
-17.77K
$20.15
-$358.07K
Nov 09, 2022
62.51K
Sale
Scheduled
Nov 07
Form 4
-50.00%
-17.77K
$20.41
-$362.54K
Nov 02, 2022
80.28K
Sale
Scheduled
Oct 31
Form 4
-33.33%
-17.77K
$20.15
-$357.97K
Oct 28, 2022
98.05K
Sale
Scheduled
Oct 26
Form 4
-1.99%
-1.27K
$19.04
-$24.13K
Sep 21, 2022
115.81K
Sale
Sep 19
Form 4
-1.76%
-1.15K
$17.75
-$20.32K
Jun 22, 2022
117.08K
Sale
Jun 17
Form 4
-0.50%
-321.00
$18.61
-$5.98K
Mar 21, 2022
117.29K
Sale
Mar 17
Form 4
684.49%
174.60K
Mar 03, 2022
253.41K
Grant
Mar 01
Form 4
-1.89%
-491.00
$24.41
-$11.99K
Dec 21, 2021
78.81K
Sale
Dec 17
Form 4
-1.81%
-479.00
$30.02
-$14.38K
Sep 21, 2021
79.30K
Sale
Sep 17
Form 4
-1.72%
-464.00
$34.13
-$15.84K
Jun 22, 2021
79.78K
Sale
Jun 17
Form 4
602.79%
67.50K
Mar 08, 2021
132.00K
Grant
Mar 04
Form 4
-14.83%
-35.00K
$29.87
-$1.76M
Feb 08, 2021
254.30K
Sale
Scheduled
Feb 05
Form 4
-56.77%
-70.00K
$35.08
-$2.46M
Oct 02, 2020
63.76K
Sale
Scheduled
Oct 01 - Oct 02
Form 4
47.06K
Feb 14, 2020
47.06K
Grant
Feb 12
Form 3
Feb 12, 2020
133.76K
Showing 32 results

SANGAMO THERAPEUTICS, INC

Investor
Updated Jun 06, 2024
Form 4
229.71%
75.00K
Jun 06, 2024
107.65K
Grant
Jun 04
Form 4
222.13%
41.65K
Jun 05, 2023
60.40K
Grant
Jun 01
Form 4
56.25K
Dec 19, 2022
56.25K
Grant
Dec 15
Form 3
Dec 19, 2022
Showing 4 results